Likely in Biological Technology

Video: Women Unsatisfied With Body and Breasts, Less Likely to Comply With Screenings, Including Mammography

The National Women's Health Resource Center's Breast Cancer Study Also Shows 82% of Women Do Not Know the #1 Risk Factor for Breast Cancer RED BANK, N.J., Sept. 23 /PRNewswire/ -- According to a new study by the not-for-profit National Women's Health Resource Center (NWHRC), the nation's lea...

Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS

Findings of Observational Study Presented at American Thoracic Society Annual Meeting RESEARCH TRIANGLE PARK, N.C. and TORONTO, May 20 /PRNewswire/ -- Patients with asthma not adequately controlled on the inhaled corticosteroid fluticasone propionate (FP) alone exp...

Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke

The REACH Registry reveals that 70% of deaths in the stable stroke population were due to a cardiovascular event other than stroke NICE, France, May 15 /PRNewswire/ -- New two-year data from the REACH Registry presented at the European Stroke Congress, highlight that among those who die ...

Genomics Likely to Replace Traditional Drug Therapies in Treating CHF

NEW YORK, April 17 /PRNewswire/ -- The market for congestive heart failure (CHF) drug treatments was estimated at $18 billion in 2007, and is expected to reach $30 billion by 2017, according to a new report by Kalorama Information, Congestive Heart Failure: Major World Markets, Volume I: Pharm...

Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates

BALTIMORE, Feb. 25 /PRNewswire/ -- Newly published data by Dr. J. Barthelow Classen shows that vaccines are particularly likely to cause diabetes in children with a strong family history of insulin dependent diabetes. Previous papers provided proof that vaccines cause diabetes in vaccine recip...

Wisconsin Economy Likely Remain Flat

Wisconsin industry executives predict Wisconsin's economy will remain flat over the next 12 months, but were much more optimistic about the national economy, reports the Wisconsin Manufacturers & Commerce (WMC) 2003 Economic Outlook Survey. At the same time, Wisconsin's business climate will likely...

Wisconsin chooses likely vendors for BadgerNet 2

Madison, Wis. Wisconsin took a step toward its new statewide video and data network Monday with Governor Jim Doyles announcement that the state favors the bid of an alliance of SBC and other telcos. The BadgerNet alliance proposes to build and manage the network dubbed BadgerNet 2 for t...

Biotech Alliance pushes ahead in SE Wisconsin with likely state funding

A drive to unite the research efforts of southeast Wisconsin received a boost late last week with an approved proposal for $2.5 million in research capital. The Legislature's Joint Committee on Finance voted 15-1 to provide funding to the Biomedical Technology Alliance, an organization of five u...

Katrina's destruction likely to speed up electronic healthcare records adoption

Years of efforts to promote electronic healthcare records have led to some adoption of the technology but there's been little sense of urgency toward that adoption. Then Hurricane Katrina slammed into the Gulf Coast, destroying countless medical records as part of her path of destruction. Kat...

WARF is likely to hold on to stem cell patent rights

Editor's note: Grady Frenchick co-authored this commentary with Michael J. Cronin, Ph.D., J.D., an intellectual property associate with Whyte Hirschboeck Dudek in Madison. A look at the facts in the dispute over three important University of Wisconsin stem cell patents - and the history b...

Georgia stem cell company likely to stay put

Madison, Wis. - It appears that Wisconsin has failed in its bid to lure a Georgia stem cell company to Madison. Aruna Biomedical , a maker of neural stem cell kits for researchers, apparently has found the financial backing it needs to remain in Athens, where it was spun out of the Universit...

Synthetech Reports First Quarter Fiscal 2010 Results

...performance for the balance of fiscal 2010. Words such as "believe," "anticipate," "expect," "estimate," "project," "will be," "will continue," "will likely result," or words or phrases of similar meanings identify forward-looking statements. Forwardlooking statements reflect management's current expectat...

AIAG and MichBio Form New Collaborative Partnership

...awareness and expectations for medical care from patients, and advances in medical technologies. While many synergies exist, some retooling will most likely be required. However, medical device manufacturing is a complimentary vertical for suppliers that have mastered strict quality certification systems i...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...ysis of the implications of new Massachusetts State tax regulations issued in Q2 2009, Shire determined during the second quarter that it was now more likely than not that these State tax credits and losses were realizable. Equity in earnings/(losses) of equity method investees Net earnings of...

Next Safety Releases Advanced Respirator for Infectious Diseases

... developing combined respirator and pulmonary drug delivery systems for soldiers to have highly sophisticated medical care that greatly enhances their likely hood of survival in battle. Next Safety engineers are experts in high-volume manufacturing. The company's engineers and managers have made more...

Plastics that convert light to electricity could have a big impact

... materials created under which conditions are most likely to meet the 10 percent efficiency goal. As res...y. Ginger noted that the polymer tested is not likely to reach the 10 percent efficiency threshold. But ...ly whether polymers they are working with are ever likely to reach the 10 percent efficiency threshold. ...

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...ff their lights for the last time. It is important to remind ourselves that the biotech industry is undergoing a major transition, a process that will likely continue for many months yet. "This is because we do not know how President Barack Obama's proposal for health care reform will fully impact th...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...a in CAP. The Company believes that an additional well-controlled clinical study designed to demonstrate efficacy in a more severe CAP population will likely be required for the approval of Restanza. In parallel, the Company will continue to advance Restanza as a biodefense agent against anthrax, plague an...

ERT Reports Second Quarter 2009 Results

...y to historical or current facts. They use words such as "aim," "anticipate," "are confident," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "look to" and other words and terms of similar meaning in conjunction with a discussion of future ope...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

... a single agent in Phase I, as well as preclinical properties indicative of likely synergy when used clinically in combination regimens," said Steve Worland, ... duplicated in the Phase II study; (v) preclinical properties indicative of likely synergy when used clinically in combination regimens; and (vi) the belief t...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

...od tolerability in Phase I, as well as preclinical properties indicative of likely synergy when used clinically in combination regimens. The upcoming Phase I...ical studies of longer duration; (iii) preclinical properties indicative of likely synergy when used clinically in combination regimens; (iv) the expectation ...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

....390 billion and $1.440 billion. Adjusted diluted earnings per share are projected to be between $2.59 and $2.67. The company now believes that it is likely to achieve the upper end of the adjusted diluted earnings per share guidance range. We now forecast reported (GAAP) diluted earnings per share to be ...

Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies

... technologies on lubricant soot levels and engine wear. Subsequent modules - to be discussed and agreed in advance by the participating members - are likely to focus on enabling ultra-low viscosity lubricants and their potential benefits in terms of friction reduction on fuel consumption, and lubricant eff...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

...rapid global spread of the virus, particularly the increasing number of cases in certain countries in the Southern Hemisphere, it appears increasingly likely that this novel H1N1 virus could be a major influenza strain circulating in the U.S. this flu season." Quest Diagnostics is currently in the ...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

...AP, currency adjusted internal growth rates to reported GAAP growth rates for the year 2009. Any significant changes in currency exchange rates would likely have a significant impact on our reported growth rates due to the volume of our sales denominated in foreign currencies. Management reports b...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

...ith the Department of Neurological Sciences at the University of Nebraska Medical Center . "This information shows that not only are AD patients more likely than their peers to suffer from other serious conditions, but their needed care takes a tremendous toll on their caregivers. All of this means increa...

Novel drug discovery tool could identify promising new therapies for Parkinson's disease

...producing neurons that are easy to examine and count. Those neurons are vulnerable to alpha-synuclein toxicity, but they were less vulnerable and more likely to survive in worms that were genetically modified to make either of the two cyclic peptides. Guy Caldwell, Ph.D., and Kim Caldwell, Ph.D., professors...

MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus

...CDC) for the year with 44 of these cases resulting in death. WNV is now the most common cause of epidemic viral encephalitis in the U.S., and it will likely remain an important cause of neurological disease for the foreseeable future. Since 2002, more than 4,500 cases of clinical WNV infection have been r...

Novel method predicts impact of a covert anthrax release

...e future course of a potential outbreak and the people and geographic areas likely to be worst affected." Anthrax has the potential to cause a large numbe...tbreak, we show that treating individuals based on early estimates is still likely to save lives overall." ...

UCR physicist receives highest honor US government gives young scientists or engineers

...cience Foundation (NSF) selects up to 20 nominees for PECASE from among those who have received awards under the NSF's CAREER program and who are most likely to become leaders of academic research and education in the twenty-first century. Lau, the first PECASE winner at UCR, received a CAREER award fro...

Monitoring water through a snake's eyes

...lorida's Everglades and officials in Germany are among those who have expressed an interest in using the technology. Skyscrapers in New York City a likely Point of Attack "Toxic materials are readily available as pesticides or herbicides in the agriculture industry, and can be harmful if consumed even...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...ed by the Three Small-Cap Companies II-5 Minimally Invasive Devices likely to Get Good Reception in Emerging Markets II-5 Awareness Drives Eur... A Glance into Other Select Markets III-71 Minimally Invasive Devices likely to Get Good Reception in Emerging Markets III-71 Cancer Market in A...

CEL-SCI Corporation Releases Letter to Shareholders

...with the winter flu season shows us how challenging our own flu season will likely be this fall and winter, even without the virus getting worse. In the Uni...ad and neck cancer. From there, we could hopefully prove that Multikine is likely to work against other solid tumors as well. Our ultimate goal in dev...

New statistical technique improves precision of nanotechnology data

...as, noise and equipment-based artifacts from experimental data could lead to more precise and reliable measurement of nanomaterials and nanostructures likely to have future industrial applications. Known as sequential profile adjustment by regression (SPAR), the technique could also reduce the amount of ...

Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

...ditional Phase II trial focused solely on a subset of MMD patients with severe insulin resistance who, based on the results of this trial, may be more likely to benefit from IPLEX(TM) treatment. Alternative methods of assessing muscle function will be considered for the proposed trial. Dr. Melvin Sh...

Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials

... best-in-class in achieving glycemic control with low incidence of hypoglycemia and neutral effect on body weight - Global Phase III trials likely to start by end 2009 - IND approved by USFDA - Glenmark takes a step closer towards becoming the first Indian company to have a truly ...

The MedZilla Report: May 2009 Employment Outlook for Biotech/Pharma/Health

...ternet's leading source for health care, pharmaceutical, and biotechnology jobs. "'Change' indicates more or fewer people looking, when it's more likely that the volume, rather than the proportion, has changed." Given the sweeping layoffs being announced by health care systems nationwide, as well ...

Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures

... treatment and low fibrosis scores F0-F3 had SVRs of 10.7% and 31.6% for the 9 mcg and 15 mcg arms Patients with cirrhosis were less likely to benefit from retreatment with INFERGEN and RBV unless they displayed previous interferon sensitivity of at least 1-log drop in viral levels on prio...

Biologist discovers pink-winged moth in Chiricahua Mountains

...ns of spring. Walsh said bats are the primary predators of moths, and so if the insects can make it through the winter, when bats hibernate, they will likely do well as the weather gets warmer. As to why L. leeae hasn't been found before, Walsh theorized that his specimen simply emerged late from hiber...

Assessment of safety and efficacy of human embryonic stem cell therapy

...nths. Barring any surprises, Stargardt disease and macular degeneration are likely to be the next two clinical applications of ES technology. Since the...stem (iPS) cell technology is further developed, hESC-derived therapies are likely to be limited to immunoprivileged sites such as the central nervous system ...